Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Dirhodium-catalyzed enantioselective C-H insertion of N-(2-benzyloxyethyl)-N-(tert-butyl)diazoacetamide and its application for the synthesis of chiral GABOB
GS 5734-metabolite
activin receptor-like kinase (ALK5)
BMS-303141 inhibits lipid synthesis in HepG2 cells with an IC50 of 8 μM
KB-R7943 inhibits high glucose-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion
PHA-767491 Hydrochloride - CAS# 942425-68-5 noxerine Dirhodium-catalyzed enantioselective C-H insertion ofPHA 767491, also known as CAY10572, is a potent, ATP competitive dual cdc7 cdk9 inhibitor (IC50 values are 10 and 34 nM respectively) that prevents initiation of DNA replication. PHA 767491 Suppresses Hepatocarcinoma Synergistically with 5 Fluorouracil. PHA 767491 in combination with 5 FU exhibited much stronger cytotoxicity and induced significant apoptosis manifested by remarkably increased caspase 3 activation and poly(ADP Ribose) polymerase
US$ 86.00
US$ 375.00
US$ 600.00
US$ 100.00
US$ 30.00
US$ 20.00